Rankings
▼
Calendar
XENE Q4 2024 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$77M
Net Income
-$66M
EPS (Diluted)
$-0.84
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$55M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$798M
Total Liabilities
$43M
Stockholders' Equity
$755M
Cash & Equivalents
$143M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$77M
-$54M
-44.3%
Net Income
-$66M
-$45M
-46.8%
← FY 2024
All Quarters
Q1 2025 →